Head of Discovery Chemistry
Mr. Turner is a co-founder of Assembly Pharmaceuticals. He has 35 years of experience as a medicinal chemist at Eli Lilly and Co., where he worked on many investigational drugs and led the team that developed the antifungal anidulafungin (Eraxis™) as a treatment for systemic Candida infections. In 2007, Mr. Turner moved to Indiana University where his research focused on lipid metabolic pathways and on identifying modifiers of HBV core protein. Mr. Turner received an SB in Chemistry from the Massachusetts Institute of Technology and an MSc from Purdue University.